Replies to post #135736 on Anavex Life Sciences Corp (AVXL)

[jimmy667]

Excellent. Well reasoned and good information.

[Jonjones325]

Agreed. If you’re gonna do it. Do it right because you only have one shot.

Missling has a communication problem not an execution problem. You can only move as fast as they let you.

He doesn’t yet understand the value of keeping the shareholders informed and probabaly doesn’t need to every step of the way. Yes. He could have adjusted his timelines and the response here would have been the same.

Does that add to his credibility. I don’t know that it does although it would be appreciated. The IR department definitely needs to be more informed and accurate in what they tell investors. That was a screw up.

Rett is the true test. Confidence will be greatly decreased if we fail. If the Alz trial starts at the same time as the final read out, that may lessen the blow of a failure.

There will be a lot of wheeling and dealing this year as the effects of repatriation take hold. We have a rich pipeline with many shots on goal. It is a no brainer for BP to look at us.

3-71 needs to move up a little quicker so we have an immediate back up.

All of this planning will start to pay off in the coming months.

[nidan7500]

Thanks Sokol...we are pretty much in the same place w/respect to the process capabilities of the FDA.

[Fireman02360]

Anavex needs to take its time and put forth the best efforts for a successful Rett trial. Not starting the Rett trial on time is not important to me. Taking the time to make sure that it has the best chance of success is important to me and should be for everyone that has an interest in Anavex for whatever reason. We do not know the reasons for the delay, but I believe everyone involved in the Rett trial feels the same that delays are not significant -- success is!

Great post sokol...finally, a post based on common sense and real-life experience. Thanks for posting your thoughts.

Happy New Year.

-Fireman